HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help
Market News Stocks News ETF News Crypto News

Akebia Therapeutics, Inc.

Contributing Author

Recent Articles by Akebia Therapeutics, Inc.

5 hours
Akebia Therapeutics to Report Third Quarter 2025 Financial Results and Discuss Recent Business Highlights AKBA GlobeNewswire
Oct-28
Akebia Therapeutics Provides Update on Vafseo for Non-Dialysis Patients AKBA GlobeNewswire
Oct-20
Akebia Therapeutics Announces Five Presentations at ASN Kidney Week 2025 AKBA GlobeNewswire
Oct-01
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) AKBA GlobeNewswire
Sep-02
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) AKBA GlobeNewswire
Aug-28
Akebia Therapeutics to Present at Upcoming Investor Conferences AKBA GlobeNewswire
Aug-21
Akebia Therapeutics and Innovative Renal Care Announce Nationwide Availability of Vafseo (vadadustat) Across All IRC Dialysis Clinics AKBA GlobeNewswire
Aug-07
Akebia Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights AKBA GlobeNewswire
Aug-06
Akebia Therapeutics to Present at Canaccord Genuity's 45th Annual Growth Conference AKBA GlobeNewswire
Aug-04
Akebia Initiates Vafseo (vadadustat) Post-Marketing Study in Conjunction with Large Dialysis Organization AKBA GlobeNewswire
Aug-01
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) AKBA GlobeNewswire
Jul-31
Akebia Therapeutics to Report Second Quarter 2025 Financial Results and Discuss Recent Business Highlights AKBA GlobeNewswire
Jul-08
Akebia Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference AKBA GlobeNewswire
Jul-01
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) AKBA GlobeNewswire
Jun-04
Vadadustat U.S. Patient Data from Global Phase 3 Clinical Program Published in Journal of the American Society of Nephrology AKBA GlobeNewswire
Jun-02
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) AKBA GlobeNewswire
May-28
Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference 2025 AKBA GlobeNewswire
May-27
Akebia Therapeutics Announces Three Poster Presentations at the European Renal Association Congress 2025 AKBA GlobeNewswire
May-13
Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference AKBA GlobeNewswire
May-08
Akebia Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights AKBA GlobeNewswire
May-01
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) AKBA GlobeNewswire
May-01
Akebia Therapeutics to Report First Quarter 2025 Financial Results and Discuss Recent Business Highlights AKBA GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.